According to filings with the U.S. Securities and Exchange Commission, Transverse Medical is raising $6,627,316.00 in new funding. Sources indicate that as part of senior management President, Eric Goslau played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Transverse Medical
Transverse Medical Inc. (TMI) is developing the POINT-GUARD Dynamic Cerebral Embolic Protection (CEP) medical device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement (TAVR). POINT-GUARD is a highly differentiated and proprietary medical device designed to more effectively provide maximum filter coverage to protect the brain, minimize embolic particles from the cerebral flow, and minimize the risk of stroke.

To learn more about Transverse Medical, visit http://www.transversemedical.com/

Contact:
Eric Goslau, President
970-236-2324
https://www.linkedin.com/in/eric-goslau-4721261a/`

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.